June 26th 2025
AI as an accelerator for data-centric, process-centric, and human-centric clinical research.
June 16th 2025
Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.
June 9th 2025
As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and sites on transparency, sustainability, and efficiency.
May 29th 2025
A blend of FSO and FSP models in the landscape of artificial intelligence can ensure CROs stay up to date with the unique demands of industry.
May 28th 2025
While randomization is required by regulatory bodies, it is up to the sponsor on how to conduct it.
Leading Clinical Projects
A survey of clinical research professionals asked: What makes you a successful project leader?
Outsourcing: China Takes Center Stage
Conversion from paper to ePRO for an instrument designed to assess diabetes' impact on quality of life.
Model Assisted Drug Development
Modeling and simulation has been heralded for some time as a possible answer to the industry's woes.
Implications of Biosimilar Development
Demonstrating biosimilarity is highly dependent on the unique characteristics of the product.
Global Supply Chain Management
From tactical to strategic: tracking the evolution of global clinical supply chain management.
Clinical Trial Community Portals
A well designed CTCP can keep everyone motivated and focused on achieving trial objectives.
CRO Timeline 1981-2012
The major industry milestones of the past 20 years.
Are Phase Labels Still Relevant?
The adoption of new, consistent definitions are needed to help demystify late phase trials.
Outsourcing Landscape
Continual change is coming as sponsors' sourcing requirements diverge from the major CROs.
What to Know About CROs
Where do CRO's turn next? What does pharma do about it?
Recruitment Drivers
Cancer trial recruitment is struggling-adult participation is limited.
Early Phase Trials
Optimizing early phase trials key to the success of novel cytotoxics and targeted therapies.
A Data Driven Approach
Are emerging markets the only answer to oncology clinical trial recruitment?
HIV Vaccine Trials: Safe for All
Researchers who work on HIV vaccines face a major challenge: convincing members of at-risk communities to volunteer for these trials.
Enrollment: More Than Numbers
Partnering with CROs and using a blinded independent central review can increase trial success.
Emerging Opportunity in Guatemala
Guatemala is multi-ethnic, multilingual, and multi-cultural-ideal for international trials.
Predicting Successful Site Performance
Research shows four factors best predict successful patient enrollment in clinical trials.
BRIC Countries Contribute to Research
BRIC governements are working to make it easier to conduct trials in country.
Here Comes the Sun(shine Act)
Drug, biological supply, and medical device manufacturers must track all payments of over $10.
In Pursuit of Enlightenment
Knowledge is power, but power is of no value if you don't exercise it.
Clinical Contracting Efficiency
A simple but overlooked way to save millions of dollars during new drug development.
Eyes Play a Focal Role in Research
Two unique techniques help characterize pharmacodynamic drug effects in healthy subjects.
Transforming R&D Through Open Innovation
Collaborative communities may hold the key to transforming a half-century's old R&D paradigm.
Archiving Approach in the UK
The proper storage of research documents remains an essential aspect of the clinical trials process.
Current Challenges of Poor R&D
Transfer of material between the supply cahins can be time consuming and complicated
Language & Culture in Global Clinical Trials
With more clinical trials conducted overseas, sponsors are facing new obstacles.
Integrated Drug Safety
Creating a drug's safety profile through the use of benefit-risk assessments during development.
Patients are not Schrödinger's Cats
Medicine is not quantum mechanics where we cannot predict when an event will occur